Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Walmart DRC | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$1.04T | 40.8x | 93.91 | CA$40.62 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$82.86B | 30.1x | CA$265.76 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
George Weston Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$82.86B | 30.1x | -3.74 | CA$24.98 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$82.86B | 30.1x | -3.69 | CA$265.05 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 8.9% Upside | Upgrade to Pro+ | |
George Weston Ser 3 Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$82.86B | 30.1x | -3.69 | CA$22.86 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston 5.20 Ser Iv Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$82.86B | 30.1x | -3.69 | CA$22.86 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
George Weston 4.75 Ser V Prf | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$82.86B | 30.1x | CA$21 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Loblaw Companies | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$65.45B | 30.6x | 4.21 | CA$220 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 5.9% Upside | Upgrade to Pro+ | |
Metro Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$22.72B | 23.4x | 5.9 | CA$104.14 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 1.1% Upside | Upgrade to Pro+ | |
Empire Company | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$13B | 19.2x | 53.71 | CA$56 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.8% Upside | Upgrade to Pro+ | |
North West | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$2.28B | 16.6x | 7.9 | CA$47.60 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.1% Upside | Upgrade to Pro+ | |
Green Thumb | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$1.81B | 26.8x | -2.26 | CA$7.81 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glass House Brands | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$343.92M | -56.2x | -0.58 | CA$8.23 | 12.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
High Tide | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$278.76M | -28.4x | -0.36 | CA$3.44 | 4.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Verano Holdings | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$271.11M | -0.7x | 0 | CA$0.76 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CareRx | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$185.49M | -47.2x | -7.38 | CA$2.93 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.1% Upside | Upgrade to Pro+ | |
Terrascend | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$173.13M | -1.4x | -0.09 | CA$0.46 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Colabor Group Inc. | Toronto | Consumer Non-Cyclicals | Food & Drug Retailing | CA$94.88M | -150x | 1.28 | CA$0.93 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Planet 13 Holdings | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$80.56M | -1.3x | -0.02 | CA$0.26 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
PharmaCorp Rx | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$59.95M | -91.3x | -1.27 | CA$0.52 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MariMed | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$51.15M | -2.2x | -0.5 | CA$0.13 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Marimed | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$50.53M | -2.2x | -0.5 | CA$0.13 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Two Hands | CBOE Canada | Consumer Non-Cyclicals | Food & Drug Retailing | CA$33.36M | -5.3x | -0.25 | CA$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Two Hands | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$33.36M | -5.3x | -0.25 | CA$0.010 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DAVIDsTEA | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$28.73M | -38.7x | -0.42 | CA$1.06 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
C21 Invest | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$25.93M | -6.5x | 0.65 | CA$0.22 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Blueberries Medical | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$7.43M | -3.6x | -0.18 | CA$0.01 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
CordovaCann | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$5.55M | -7x | -0.09 | CA$0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ayurcann Holdings | CSE | Consumer Non-Cyclicals | Food & Drug Retailing | CA$4.87M | -1.6x | -0.05 | CA$0.03 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rocky Mountain Liquor | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$4.07M | -2x | 0 | CA$0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Astron Connect | TSXV | Consumer Non-Cyclicals | Food & Drug Retailing | CA$605.42K | -8.1x | -0.12 | CA$0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |